1. Home
  2. LNN vs EVO Comparison

LNN vs EVO Comparison

Compare LNN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNN
  • EVO
  • Stock Information
  • Founded
  • LNN 1954
  • EVO 1993
  • Country
  • LNN United States
  • EVO Germany
  • Employees
  • LNN N/A
  • EVO N/A
  • Industry
  • LNN Industrial Machinery/Components
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNN Industrials
  • EVO Health Care
  • Exchange
  • LNN Nasdaq
  • EVO Nasdaq
  • Market Cap
  • LNN 1.5B
  • EVO 1.6B
  • IPO Year
  • LNN 1988
  • EVO 2021
  • Fundamental
  • Price
  • LNN $124.06
  • EVO $3.60
  • Analyst Decision
  • LNN Hold
  • EVO Buy
  • Analyst Count
  • LNN 1
  • EVO 2
  • Target Price
  • LNN $128.00
  • EVO $5.90
  • AVG Volume (30 Days)
  • LNN 114.0K
  • EVO 101.3K
  • Earning Date
  • LNN 04-03-2025
  • EVO 04-17-2025
  • Dividend Yield
  • LNN 1.16%
  • EVO N/A
  • EPS Growth
  • LNN 12.44
  • EVO N/A
  • EPS
  • LNN 7.03
  • EVO N/A
  • Revenue
  • LNN $647,542,000.00
  • EVO $825,103,013.00
  • Revenue This Year
  • LNN $11.29
  • EVO $3.70
  • Revenue Next Year
  • LNN $3.37
  • EVO $10.32
  • P/E Ratio
  • LNN $17.65
  • EVO N/A
  • Revenue Growth
  • LNN 0.46
  • EVO 1.99
  • 52 Week Low
  • LNN $109.27
  • EVO $2.84
  • 52 Week High
  • LNN $140.26
  • EVO $7.77
  • Technical
  • Relative Strength Index (RSI)
  • LNN 45.62
  • EVO 56.15
  • Support Level
  • LNN $114.81
  • EVO $3.27
  • Resistance Level
  • LNN $129.26
  • EVO $3.40
  • Average True Range (ATR)
  • LNN 5.61
  • EVO 0.14
  • MACD
  • LNN 0.20
  • EVO 0.07
  • Stochastic Oscillator
  • LNN 46.04
  • EVO 84.44

About LNN Lindsay Corporation

Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: